OpenAlex
Works that cite this article, indexed by OpenAlex.
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19
Cellular Signalling 74 (2020)
Poduri Ramarao; Gaurav Joshi; Gowraganahalli Jagadeesh
Diagnostic and Treatment Strategies for COVID-19
AAPS PharmSciTech 21(6) (2020)
Humzah Jamshaid; Fatima Zahid; Intisar ud Din; Alam Zeb; Han Gon Choi; Gul Majid Khan; Fakhar ud Din
The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy
International Journal of Molecular Sciences 22(11) (2021)
Shirin Kouhpayeh; Laleh Shariati; Maryam Boshtam; Ilnaz Rahimmanesh; Mina Mirian; Yasaman Esmaeili; Malihe Najaflu; Negar Khanahmad; Mehrdad Zeinalian; Maria Trovato; Franklin R. Tay; Hossein Khanahmad; Pooyan Makvandi
Hypothetical targets and plausible drugs of coronavirus infection caused by SARS‐CoV‐2
Transboundary and Emerging Diseases 68(2) (2020)
Faezeh Almasi; Fatemeh Mohammadipanah
Drug-Based Therapeutic Strategies for COVID-19-Infected Patients and Their Challenges
Future Microbiology 16(18) (2021)
Khatereh Zarkesh; Elaheh Entezar-Almahdi; Parisa Ghasemiyeh; Mohsen Akbarian; Marzieh Bahmani; Shahrzad Roudaki; Rahil Fazlinejad; Soliman Mohammadi‐Samani; Negar Firouzabadi; Majid Hosseini; Fatemeh Farjadian
An effective drug against COVID-19: reality or dream?
Expert Review of Respiratory Medicine 15(4) (2020)
Atieh Yaghoubi; Saeid Amel Jamehdar; Aref Movaqar; Nasrin Milani; Saman Soleimanpour
Repurposing of thalidomide and its derivatives for the treatment of SARS‐coV‐2 infections: Hints on molecular action
British Journal of Clinical Pharmacology 87(10) (2021)
Lakshmikirupa Sundaresan; Suvendu Giri; Himanshi Singh; Suvro Chatterjee
A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease
Saudi Journal of Biological Sciences 29(2) (2021)
Muhammad Ikram Ullah; Yasir Ali; Muhammad Ramzan Khan; Muhammad Ramzan Khan; Inam Ullah Khan; Bing Yan; Mudassir Khan; Mudassir Khan; M.Y. Malik
Anti-rheumatic drugs as potential anti-inflammatory, immunomodulatory agents against COVID-19: A systematic review
Pharmaceutical Sciences (2021)
Reza Sinaei; Sara Pezeshki; Ali Asadipour; Reza Shiari; Roya Sinaei; Ali Sinaei
The SARS-Cov-2 Proliferation Blocked by a Novel and Potent Main Protease Inhibitor via Computer-aided Drug Design.
PubMed 20(3) (2021)
Sepideh Shayan; Shahab Jamaran; Rafee Habib Askandar; Arian Rahimi; Azam Elahi; Chiako Farshadfar; Noeman Ardalan
COVID-19: A novel holistic systems biology approach to predict its molecular mechanisms (in vitro) and repurpose drugs
DARU Journal of Pharmaceutical Sciences 31(2) (2023)
Marzieh Sameni; Seyed Amir Mirmotalebisohi; Sadaf Dadashkhan; Sepideh Ghani; Maryam Abbasi; Effat Noori; Hakimeh Zali
Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form.
PubMed 20(4) (2021)
Payam Tabarsi; Hossein Vahidi; Ali Saffaei; Seyed Mohammad Reza Hashemian; Hamidreza Jamaati; Bahram Daraei; Arash Mahboubi; Farzad Kobarfard; Majid Marjani; Afshin Moniri; Zahra Abtahian; Atefeh Abedini; Alireza Eslaminejad; Jalal Heshmatnia; Maryam Sadat Mirenayat; Atefeh Fakharian; Sharareh Seifi; Mohsen Sadeghi; Alireza Dastan; Sara Haseli; Seyed Alireza Nadji; Raha Eskandari; Sahar Yousefian; Mohammad Varahram; Alireza Zali; Ali Akbar Velayati; Farzaneh Dastan
Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?
Clinics in Dermatology 39(3) (2021)
Snejina Vassileva; Valeria Mateeva; Kossara Drenovska